Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome-Reference-Cited by-同舟云学术

Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome

Published:1987-08 Issue:4 Volume:10 Page:389-395
ISSN:0391-4097
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Prelević G. M.,Würzburger M. I.,Perić Lj. A.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/BF03348155.pdf

Reference21 articles.

1. LeBlanc H., Lachelin G.C.L., Abu-Fadil S., Yen S.S.C. Effects of dopamine infusion on pituitary hormone secretion in humans. J. Clin. Endocrinol. Metab. 43: 668, 1976.

2. Lachelin G.C.L., LeBlanc H., Yen S.S.C. The inhibitory effects of dopamine agonists on LH release in women. J. Clin. Endocrinol. Metab. 44: 728, 1977.

3. Judd S.J., Rakoff J.S., Yen S.S.C. Inhibition of gonadotrophin and prolactin release by dopamine-effect of endogenous estradiol levels. J. Clin. Endocrinol. Metab. 47: 494, 1978.

4. Zarate A., Canales E.S., Soria J., Mariero P.J., McGregor C. Effect of acute administration of L-dopa on serum concentrations of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in patients with the amenorrhoea-galactorrhoea syndrome. Neuroendocrinology 12: 362, 1973.

5. Judd S.J., Rigg L.A., Yen S.S.C. The effects of ovariectomy and estrogen treatment on the dopamine inhibition of gonadotropin and prolactin release. J. Clin. Endocrinol. Metab. 49: 182, 1979.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy of metformin combined with cabergoline versus metformin alone in patients with PCOS and hyperprolactinemia: A systematic review and meta-analysis of randomized controlled trials;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-08

2. Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects;Life;2023-10-26

3. Improving pregnancy rate in infertile patients with polycystic ovarian syndrome receiving clomiphene citrate and cabergoline in euprolactinomic women in single cycle treatment;Ginekologia Polska;2022-08-16

4. To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study;Advances in Medical Sciences;2022-03

5. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome;European Journal of Clinical Investigation;2018-06-13